Ikonisys S.A. (ALIKO.PA)
EUR 1.47
(8.09%)
EUR 1.47
(8.09%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -2.19 Million EUR | 9.9% |
| 2022 | -2.43 Million EUR | -213.19% |
| 2021 | -777.42 Thousand EUR | -330.38% |
| 2020 | -180.63 Thousand EUR | 27.99% |
| 2019 | -250.85 Thousand EUR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -1.35 Million EUR | 0.0% |
| 2023 Q2 | -1.05 Million EUR | -100.0% |
| 2023 FY | -2.39 Million EUR | 1.83% |
| 2023 Q3 | -665.59 Thousand EUR | 37.16% |
| 2023 Q1 | -529.57 Thousand EUR | 69.51% |
| 2023 Q4 | -640.13 Thousand EUR | 3.83% |
| 2022 Q3 | -868.4 Thousand EUR | 14.56% |
| 2022 Q2 | -1.01 Million EUR | -100.0% |
| 2022 Q1 | -508.16 Thousand EUR | -66.4% |
| 2022 FY | -2.43 Million EUR | -213.19% |
| 2022 Q4 | -1.73 Million EUR | -100.0% |
| 2021 FY | -777.42 Thousand EUR | -330.38% |
| 2021 Q1 | -102.99 Thousand EUR | -498.39% |
| 2021 Q4 | -305.38 Thousand EUR | -70.49% |
| 2021 Q3 | -179.11 Thousand EUR | 13.05% |
| 2021 Q2 | -206 Thousand EUR | -100.0% |
| 2020 Q1 | 76.49 Thousand EUR | 0.0% |
| 2020 Q4 | 25.85 Thousand EUR | 0.0% |
| 2020 FY | -180.63 Thousand EUR | 27.99% |
| 2020 Q3 | 25.85 Thousand EUR | -66.2% |
| 2020 Q2 | 76.49 Thousand EUR | 0.0% |
| 2019 FY | -250.85 Thousand EUR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Affluent Medical SA | -13.06 Million EUR | 83.21% |
| Bluelinea Société Anonyme | -1.61 Million EUR | -36.031% |
| Carmat SA | -52.51 Million EUR | 95.823% |
| Diagnostic Medical Systems S.A. | -2.26 Million EUR | 3.147% |
| Euromedis Groupe | -5.55 Million EUR | 60.524% |
| Eurobio Scientific Société anonyme | 10.14 Million EUR | 121.632% |
| Implanet S.A. | -6.15 Million EUR | 64.382% |
| Median Technologies SA | -23 Million EUR | 90.465% |
| SpineGuard SA | -3.97 Million EUR | 44.827% |
| Theraclion SA | -3.15 Million EUR | 30.446% |
| Euroapi S.A. | -234.3 Million EUR | 99.064% |
| Guerbet SA | 38.67 Million EUR | 105.673% |
| Ion Beam Applications SA | 5.09 Million EUR | 143.082% |
| Koninklijke Philips N.V. | -115 Million EUR | 98.092% |
| Sequana Medical NV | -29.49 Million EUR | 92.561% |